Adam Beaty is more than just your typical options strategist. His passion for business and his entrepreneurial mindset have taken him on a stock trading adventure. Starting with only $500 in his portfolio, Adam began to visualize his dream. Already 'hooked' on the stock market and the charts they produced, he further developed a unique awareness of a niche market, options, and the infinite plays he could run with them.
His work with weekly options earned him recognition in the Wall Street Journal at the age of twenty-four. After receiving dual majors in Finance and Marketing, and graduating Magna Cum Laude, Adam continues to study the market, pour through the charts, paying attention to the smallest details that may have an affect as he looks for the next big setup!
Ever feel like trading is like rolling dice? In a way, it is, because every mathematical model of the market includes a stochastic aspect. But I believe we can load the dice in our favor through the use of statistics. Understanding both the stock market and each individual stock as a sort of random process with its own characteristics allows us to more accurately predict what it will do in the future. Coupling statistics with fundamental analysis, I have the goal of revealing to you the hidden patterns within stocks so that you may do what you wish with that information.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
The Clinically Sound Investor is a pharmacist for a large retail corporation, with a PharmD and a BA in psychology. Fascinated by watching the rise of Walmart and Apple after 2008, he now follows the advice "know thyself" and puts expertise of understaning scientific literature to research biotechnology stocks. His investments early on were driven by binary events such as FDA Advisory Committee meetings and PDUFA dates (approvals). Despite initial successes, there were too few of these events, so he expanded into predicting Phase II/III trial results.
His writings should not be considered financial advice or the basis for investment decisions. While his interpretations of clinical trial results--which may be overlooked or even thoroughly misunderstood by Wall Street--could be helpful, they're only as good as the original reports they come from. Although written by scientists and doctors, there will always be a slant from the sponsoring company, or worse (like, say, missing data...).
Costas began his trading career in 1998, hired by Gateway Partners, an Equity Options Trading Specialist Unit, on the Philadelphia Stock Exchange (PHLX). During his time there, Costas gained valuable experience navigating through the financial meltdown that saw the downfall of hedge fund, Long Term Capital, and the Russian Currency Crisis when trading volatility levels reached unprecedented levels.
Costas became a Senior Equity Options Market Maker for the firm, eventually leaving to join a proprietary trading desk where he made markets for large customer and institutional orders.
Costas has more than seven years of experience making options markets. He has also trained and educated several junior traders on option theory, risk analysis, and strategy.
He’s looking forward to helping self-directed investing hobbyists find success through the utilization and understanding of how options play an important role in achieving financial objectives.
Gary Tanashian is proprietor of NFTRH.com and Biiwii.com. Actionable, hype-free technical, macro economic and sentiment analysis is provided in the premium market report 'Notes From the Rabbit Hole' (http://nftrh.com/nftrh-premium/). Complimentary analysis and commentary is available at the public site (http://nftrh.com), at http://biiwii.com and by email with our free - and spam free - eLetter service (http://nftrh.com/free-eletter/).